HLA Typing Market Worth $1.9 Billion by 2029
o
HLA Typing
Market Worth $1.9 Billion by 2029
|
Meticulous Research®—a leading global
market research company, published a research report titled, “HLA Typing Market by Product (Instruments,
Software), Technology (Molecular [PCR, Sequencing [Sangers, NGS]], Serology),
Application (Diagnostics [Cross Match, Cancer, Infectious Disease,
Transfusion], Research), End User, and Geography - Global Forecast to
2029”.
Download free Sample Report Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5311
According to this latest publication from
Meticulous Research®, the global HLA typing market is projected to grow at a CAGR of
5.6% during the forecast period to reach $1.9 billion by 2029. The high
growth of the HLA typing market is attributed to the increasing number of
organ transplants and technological advancements in HLA typing. Moreover,
increasing awareness about organ donations is creating growth opportunities
for the global HLA typing market. However, the high costs of molecular
techniques related to HLA typing limit the market growth. Additionally, the
shortage of organs for transplantation poses a challenge to this market's
growth.
HLA Typing Market: Future
Outlook
The global HLA typing market is segmented by
Product (Instruments, Consumables, Software & Services), Technology
(Molecular technologies [PCR-based Molecular Techniques {Sequence-specific
Primers, Sequence-specific Oligonucleotide, and Other PCR PCR-based Molecular
Techniques}, Sequencing-based Molecular Technologies {Sanger Sequencing, Next
Generation Sequencing, Pyrosequencing}, DNA Microarray], Non-molecular
Technologies), Application (Diagnostics [Donor Recipient Cross-matching,
Transfusion Therapy, and Other Diagnostics Applications], Research), End User
(Diagnostics Labs, Hospital & Transplant Centers, Academic & Research
Institutes) and Geography. The study also evaluates industry competitors and
analyzes the regional and country markets.
Based on product, in 2022, the
consumables segment is estimated to account for the largest share of the HLA
typing market. The large share of this segment is attributed to the growing
applications of molecular assay techniques in HLA typing, the growing adoption
of molecular diagnostic techniques in research studies, increasing emphasis on
effective and early patient profiling for organ transplantation, and the
rising number of organ transplantations.
Based on technology, in 2022, the
molecular technologies segment is estimated to account for the largest
share of the HLA typing market. Factors contributing to the large share of
this segment include the advancements in molecular assays and the benefits of
molecular techniques over non-molecular techniques. Molecular assays offer low
turnaround times, multi-sample study capabilities, high procedural efficacy,
and real-time sample analysis, increasing the demand for molecular assays
compared to non-molecular assays.
Speak to analyst: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5311
Based on application, in 2022, the
diagnostics segment is estimated to account for the largest share of the HLA
typing market. The increasing use of HLA typing in disease diagnosis and
pathogenesis and the growing incidences of infectious and chronic diseases are
the factors expected to propel the growth of this segment. The burden of
infectious and non-infectious diseases is rising globally. For instance,
according to the International Agency for Research on Cancer, the number of
new cancer cases is estimated to increase by 59.2% from 2020 to 2040 in Asia
and 21% from 2020 to 2040 in Europe. Thus, high disease prevalence contributes
to the growth of this segment.
Based on end user, in 2022, the
diagnostic laboratories segment is expected to account for the largest share
of the HLA typing market. The diagnostic laboratories carry out the maximum
number of HLA typing procedures. In most countries, hospitals are outsourcing
their diagnostic capabilities. Therefore, although HLA typing is preferred to
be carried out in the transplant facility, it is ultimately carried out in the
diagnostic centers due to outsourcing. In addition, diagnostic centers can
also carry out the pathogenesis of infectious diseases, contributing to the
large share of this segment in the HLA typing market.
This research report analyzes major
geographies and provides a comprehensive analysis of North America (U.S.,
Canada), Europe (Germany, France, U.K., Italy, Spain, and the Rest of Europe),
Asia-Pacific (Japan, China, India, and RoAPAC), Latin America (Brazil, Mexico,
and Rest of Latin America), and the Middle East & Africa.
Based on geography, in 2022, North
America is expected to dominate the global HLA typing market, followed by
Europe and Asia-Pacific. The high prevalence of cancer and autoimmune
diseases, the high number of organ transplants, and government funding for HLA
and killer cell immunoglobulin-like receptors (KIR) for immune-mediated
diseases support the growth of the North American HLA typing market.
Key Players:
The key players operating in the global HLA
typing market are Thermo Fisher Scientific Inc. (U.S.), Bio-rad Laboratories
(U.S.), Qiagen N.V. (Netherlands), Genome Diagnostics B.V. (GenDx)
(Netherlands), Illumina, Inc. (U.S.), CareDx (U.S.), Immucor Inc. (U.S.), TBG
Diagnostics Limited (Australia), BAG Diagnostic GmbH (Germany), Omixon Inc.
(Hungary), Luminex Corporation (U.S.), inno-train Diagnostik GmbH (Germany),
Pacific Biosciences of California, Inc. (U.S.), and Fujirebio Holdings, Inc.
(Japan).
Quick Buy: https://www.meticulousresearch.com/Checkout/76618224
Key questions answered in
the report-
· What is
the current value of revenue generated by HLA typing products across the
globe?
· At what
rate is the demand for global HLA typing products projected to grow for the
next 5-7 years?
· What is
the historical market size and growth rate for HLA typing across the globe?
· What are
the major factors impacting the growth of this market at the global and
regional levels? What are major opportunities for existing market players and
new entrants in the market?
· What
impact does the current COVID-19 pandemic have on the HLA typing market at
various levels in the value chain?
· Which
segments in terms of the product, technology, application, and end user are
creating the major traction for the vendors in this market?
· What are
the key geographical trends in this market? Which regions/countries are
expected to offer significant growth opportunities for the vendors operating
in the global HLA typing market?
· Who are
the major players in the global HLA typing market? And what are their specific
instruments/consumables/software & services in the HLA typing industry?
· What
recent developments have taken place in global HLA typing, and how these
strategic developments are creating a global impact in this market?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment